Patents by Inventor Claudio Schteingart

Claudio Schteingart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vasopressin-2 receptor agonists
    Patent number: 10745443
    Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: August 18, 2020
    Assignee: FERRING B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Pierre Riviere
  • VASOPRESSIN-2 RECEPTOR AGONISTS
    Publication number: 20190194257
    Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.
    Type: Application
    Filed: September 27, 2018
    Publication date: June 27, 2019
    Applicant: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Pierre Riviere
  • Vasopressin-2 receptor agonists
    Patent number: 10131692
    Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: November 20, 2018
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Pierre Riviere
  • VASOPRESSIN-2 RECEPTOR AGONISTS
    Publication number: 20150307555
    Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.
    Type: Application
    Filed: July 25, 2014
    Publication date: October 29, 2015
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Pierre Riviere
  • Peptidic vasopressin receptor agonists
    Patent number: 8778881
    Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: July 15, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent LaPorte, Robert Felix Galyean, Pierre J.M. Riviere
  • Oxytocin analogues
    Patent number: 8673841
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia compromised lactation conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: March 18, 2014
    Assignee: Ferring B.V.
    Inventors: Sudar Alagarsamy, Robert Galyean, Kaszimierz Wisniewski, Claudio Schteingart
  • Peptidic Vasopressin Receptor Agonists
    Publication number: 20120196808
    Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: March 1, 2012
    Publication date: August 2, 2012
    Applicant: FERRING B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent LaPorte, Robert Felix Galyean, Pierre Riviere
  • Peptidic vasopressin receptor agonists
    Patent number: 8148319
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: April 3, 2012
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent Laporte, Robert Felix Galyean, Pierre Riviere
  • OXYTOCIN ANALOGUES
    Publication number: 20110044905
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia compromised lactation conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: March 30, 2009
    Publication date: February 24, 2011
    Applicant: Ferring B.V.
    Inventors: Sudar Alagarsamy, Robert Galyean, Kazimierz Wisniewski, Claudio Schteingart
  • Peptidic vasopressin receptor agonists
    Publication number: 20090054309
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: August 3, 2005
    Publication date: February 26, 2009
    Applicant: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent Laporte, Robert Felix Galyean, Pierre Riviere
  • Amide or thioamide derivatives and their use in the treatment of pain
    Publication number: 20070197653
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of pain and disorders related thereto as well as a method for treatment of pain and disorders related thereto, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: October 14, 2004
    Publication date: August 23, 2007
    Applicant: CARA THERAPEUTICS, INC.
    Inventors: Chia-Ping Chang, Jacek Stalewski, Pierre Riviere, Kazimierz Wesniewski, Claudio Schteingart